The estimated Net Worth of Robert S Fletcher is at least $8.22 Millón dollars as of 22 May 2024. Mr. Fletcher owns over 2,007 units of Stryker stock worth over $3,259,050 and over the last 5 years he sold SYK stock worth over $1,811,363. In addition, he makes $3,146,770 as Vice President y Chief Legal Officer at Stryker.
Sign up
Mr. Fletcher SYK stock SEC Form 4 insiders trading
Robert has made over 8 trades of the Stryker stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,007 units of SYK stock worth $668,311 on 22 May 2024.
The largest trade he's ever made was exercising 4,272 units of Stryker stock on 30 April 2022 worth over $1,565,047. On average, Robert trades about 1,007 units every 78 days since 2020. As of 22 May 2024 he still owns at least 8,896 units of Stryker stock.
You can see the complete history of Mr. Fletcher stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Fletcher biography
Robert S. Fletcher serves as Vice President, Chief Legal Officer of the Company. Mr. Fletcher held various legal leadership roles with Johnson & Johnson for the previous 14 years, most recently as the Worldwide Vice President, Litigation.
What is the salary of Robert Fletcher?
As the Vice President y Chief Legal Officer of Stryker, the total compensation of Robert Fletcher at Stryker is $3,146,770. There are 3 executives at Stryker getting paid more, with Kevin Lobo having the highest compensation of $14,974,800.
How old is Robert Fletcher?
Robert Fletcher is 49, he's been the Vice President y Chief Legal Officer of Stryker since 2019. There are 21 older and no younger executives at Stryker. The oldest executive at Stryker Corp. is Srikant Datar, 67, who is the Independent Director.
Insiders trading at Stryker
Over the last 21 years, insiders at Stryker have traded over $2,226,515,535 worth of Stryker stock and bought 219,711 units worth $9,400,673 . The most active insiders traders include Ronda E Stryker, Pat Stryker y Jon L Stryker. On average, Stryker executives and independent directors trade stock every 6 days with the average trade being worth of $10,449,767. The most recent stock trade was executed by Viju Menon on 27 August 2024, trading 600 units of SYK stock currently worth $213,000.
What does Stryker do?
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
What does Stryker's logo look like?
Complete history of Mr. Fletcher stock trades at Stryker
Stryker executives and stock owners
Stryker executives and other stock owners filed with the SEC include:
-
Kevin Lobo,
Chairman of the Board, Chief Executive Officer -
timothy Scannell,
President, Chief Operating Officer -
Glenn Boehnlein,
Chief Financial Officer, Vice President -
Robert Fletcher,
Vice President, Chief Legal Officer -
Viju Menon,
Group President - Global Quality and Operations -
Kevin A. Lobo,
Chairman, CEO & Pres -
Timothy J. Scannell,
Pres & COO -
Glenn S. Boehnlein,
VP & CFO -
Viju S. Menon,
Group Pres of Global Quality & Operations -
Robert S. Fletcher,
VP & Chief Legal Officer -
Allan Golston,
Lead Independent Director -
Andrew Silvernail,
Independent Director -
Roch Doliveux,
Independent Director -
Sherilyn McCoy,
Independent Director -
Rajeev Suri,
Independent Director -
Ronda Stryker,
Independent Director -
Srikant Datar,
Independent Director -
Mary Brainerd,
Independent Director -
Preston Wells,
Vice President - Investor Relations -
Yin Becker,
Vice President - Communications, Public Affairs and Corporate Marketing -
William Berry,
Principal Accounting Officer, Vice President, Corporate Controller -
M. Kathryn Fink,
Chief Human Resource Officer, Vice President -
M. Kathryn Fink,
VP & Chief HR Officer -
William E. Berry Jr.,
VP & Chief Accounting Officer -
Dana S. McMahon,
VP & Chief Compliance Officer -
Alan Douville,
VP, Chief Information Officer & Chief Information Security Officer -
Robert C. Cohen,
CTO and VP of Global R&D - Joint Replacement -
Louise Francesconi,
Director -
David Floyd,
Group President, Orthopaedics -
Bijoy Sagar,
VP, Chief Information Officer -
Howard E Jr Cox,
Director -
Graham A Mc Lean,
President, Asia-Pacific -
Lonny J Carpenter,
Group President -
Michael Damon Hutchinson,
General Counsel -
Katherine Ann Owen,
VP, Strategy and IR -
William R Jellison,
VP and CFO -
Curtis E Hall,
VP, General Counsel -
Steven P Benscoter,
VP, Human Resources -
Howard L Lance,
Director -
Donald M Engelman,
Director -
Andrew Grant Fox Smith,
President -
Michael P Mogul,
Group President -
Tony M Mc Kinney,
V.P., CAO -
Stephen P Macmillan,
President and COO -
Marcia S Kaminsky,
V.P., Comms. & Public Affairs -
Michael W Rude,
VP of Human Resources -
Curt R Hartman,
V.P., Finance -
Ramesh Subrahmanian,
Group President, International -
Scott P Bruder,
VP, Chief Med&Scientific Off. -
Luciano Cattani,
V.P. -
James E Kemler,
Vice President -
Thomas R Winkel,
Vice Pesident -
John W Brown,
Chairman and CEO -
Jon L Stryker,
10% owner -
Pat Stryker,
10% owner -
Jerome H Grossman,
Director -
John S Lillard,
Director -
Dean H Bergy,
Vice President, CFO & Secretar -
James R Lawson,
Vice President -
Gerard Thomas,
10% owner -
Stephen Si Johnson,
Vice President -
Mason Elizebeth S Upjohn,
10% owner -
Edward B Lipes,
Vice President -
William U Parfet,
Director -
Tatum Lisa M Skeete,
Director -
Rachel Ruggeri,
Director -
Giovanni Caforio,
Director -
James Andrew Pierce,
Group President -
Spencer S Stiles,
Group President